Reis, J.; Teixeira, A.R.; Gonçalves, A.V.; Moreira, R.I.; Silva, T.P.; Timóteo, A.T.; Ferreira, R.C.
Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients. J. Clin. Med. 2022, 11, 2935.
https://doi.org/10.3390/jcm11102935
AMA Style
Reis J, Teixeira AR, Gonçalves AV, Moreira RI, Silva TP, Timóteo AT, Ferreira RC.
Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients. Journal of Clinical Medicine. 2022; 11(10):2935.
https://doi.org/10.3390/jcm11102935
Chicago/Turabian Style
Reis, João, Ana Rita Teixeira, António Valentim Gonçalves, Rita Ilhão Moreira, Tiago Pereira Silva, Ana Teresa Timóteo, and Rui Cruz Ferreira.
2022. "Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients" Journal of Clinical Medicine 11, no. 10: 2935.
https://doi.org/10.3390/jcm11102935
APA Style
Reis, J., Teixeira, A. R., Gonçalves, A. V., Moreira, R. I., Silva, T. P., Timóteo, A. T., & Ferreira, R. C.
(2022). Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients. Journal of Clinical Medicine, 11(10), 2935.
https://doi.org/10.3390/jcm11102935
